Kane Biotech Inc (KNE.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2010 | 12-2009 | 12-2008 | 12-2007 | 12-2006 | |
| Cash Flows From Operating Activities | |||||
| Depreciation Amortization | 29 | 39 | 42 | 106 | 36 |
| Accounts receivable | 67 | -3 | -65 | 21 | 2 |
| Other Working Capital | 67 | 18 | -93 | 1 | -40 |
| Other Operating Activity | -955 | -819 | -958 | -926 | -841 |
| Operating Cash Flow | $-792 | $-764 | $-1,073 | $-798 | $-843 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 0 | -1 | 0 | -167 | -186 |
| Purchase Sale Intangibles | -130 | -119 | -151 | N/A | N/A |
| Investing Cash Flow | $-130 | $-120 | $-151 | $-167 | $-186 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | N/A | 1,140 | 1,428 | 621 | 1,312 |
| Other Financing Activity | 305 | 0 | 0 | 0 | 24 |
| Financing Cash Flow | $305 | $1,140 | $1,428 | $621 | $1,336 |
| Beginning Cash Position | 805 | 549 | 345 | 689 | 382 |
| End Cash Position | 188 | 805 | 549 | 345 | 689 |
| Net Cash Flow | $-617 | $256 | $204 | $-345 | $307 |
| Free Cash Flow | |||||
| Operating Cash Flow | -792 | -764 | -1,073 | -798 | -843 |
| Capital Expenditure | -130 | -120 | -151 | -167 | -186 |
| Free Cash Flow | -922 | -884 | -1,224 | -966 | -1,029 |